New hope for tough lung cancer: drug plus radiation combo shows promise in early trial

This early study tests whether combining a drug called lurbinectedin with radiation therapy is safe for people with small cell lung cancer that has one new tumor after initial treatment. The drug works by damaging cancer cell DNA, similar to radiation. The goal is to see if this combination causes fewer severe side effects than standard treatments. Only 9 participants were enrolled, and the study focuses on safety and how long people live without the cancer growing.